These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 17177609)

  • 1. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
    Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
    Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Varich NL; Ilyushina NA; Gambaryan AS; Krylov PS; Kaverin NV
    Arch Virol; 2007; 152(6):1139-45. PubMed ID: 17294090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generation of attenuated H5N1 and H5N2 subtypes of influenza virus recombinants by reverse genetics system].
    Lu JH; Long JX; Shao WX; Wei DP; Liu XF
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):53-7. PubMed ID: 15847163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
    Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet.
    Zhang Y; Zhang Q; Kong H; Jiang Y; Gao Y; Deng G; Shi J; Tian G; Liu L; Liu J; Guan Y; Bu Z; Chen H
    Science; 2013 Jun; 340(6139):1459-63. PubMed ID: 23641061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.
    Moatasim Y; Kandeil A; Mostafa A; Elghaffar SKA; El Shesheny R; Elwahy AHM; Ali MA
    Arch Virol; 2017 Oct; 162(10):2959-2969. PubMed ID: 28620809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-reassortment amino acid change in the hemagglutinin of a human-avian influenza H5N1 reassortant virus alters its antigenic specificity.
    Rudneva IA; Timofeeva TA; Ilyushina NA; Varich NL; Kochergin-Nikitsky KS; Kaverin NV
    Acta Virol; 2008; 52(3):181-4. PubMed ID: 18999893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of highly pathogenic H5N1 avian influenza viruses isolated from poultry markets in central China.
    Chen J; Fang F; Yang Z; Liu X; Zhang H; Zhang Z; Zhang X; Chen Z
    Virus Res; 2009 Dec; 146(1-2):19-28. PubMed ID: 19720095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A Virus.
    Yu Y; Wang X; Jin T; Wang H; Si W; Yang H; Wu J; Yan Y; Liu G; Sang X; Wu X; Gao Y; Xia X; Yu X; Pan J; Gao GF; Zhou J
    J Virol; 2015 Sep; 89(17):8806-15. PubMed ID: 26085150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.
    Bender C; Hall H; Huang J; Klimov A; Cox N; Hay A; Gregory V; Cameron K; Lim W; Subbarao K
    Virology; 1999 Feb; 254(1):115-23. PubMed ID: 9927579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genesis of a pandemic influenza virus.
    Russell CJ; Webster RG
    Cell; 2005 Nov; 123(3):368-71. PubMed ID: 16269328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks.
    Mundt E; Gay L; Jones L; Saavedra G; Tompkins SM; Tripp RA
    Arch Virol; 2009; 154(8):1241-8. PubMed ID: 19575275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary trajectories and diagnostic challenges of potentially zoonotic avian influenza viruses H5N1 and H9N2 co-circulating in Egypt.
    Naguib MM; Arafa AS; El-Kady MF; Selim AA; Gunalan V; Maurer-Stroh S; Goller KV; Hassan MK; Beer M; Abdelwhab EM; Harder TC
    Infect Genet Evol; 2015 Aug; 34():278-91. PubMed ID: 26049044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96.
    Lee CW; Song CS; Lee YJ; Mo IP; Garcia M; Suarez DL; Kim SJ
    Avian Dis; 2000; 44(3):527-35. PubMed ID: 11006999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
    Jadhao SJ; Nguyen DC; Uyeki TM; Shaw M; Maines T; Rowe T; Smith C; Huynh LP; Nghiem HK; Nguyen DH; Nguyen HK; Nguyen HH; Hoang LT; Nguyen T; Phuong LS; Klimov A; Tumpey TM; Cox NJ; Donis RO; Matsuoka Y; Katz JM
    Arch Virol; 2009; 154(8):1249-61. PubMed ID: 19578928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.